Theriva Biologics (TOVX) Non-Current Debt (2022 - 2026)
Theriva Biologics' Non-Current Debt came in at $1.62 million for Q2 2026, down 1.2% from $1.64 million a year earlier and down 0.4% from the prior quarter.
Powered by 
Analysis
Theriva Biologics (TOVX) Non-Current Debt (2022 - 2026) Analysis & Trends
At the end of FY2025, Theriva Biologics' Non-Current Debt was $1.67 million.
- Non-Current Debt carries a three-year compound annual growth rate of 96.3% (FY2022 to FY2025).
- Going back by year, Non-Current Debt was $92,000 in FY2024 (-43.2%), $162,000 in FY2023 (-26.7%) and $221,000 in FY2022.
- The Q2 2026 figure represents the lowest quarterly Non-Current Debt since Q1 2025.
- Year-over-year, Non-Current Debt increased in two of the last five quarters, with growth averaging 155.0%.
- The fastest year-over-year change in Non-Current Debt over five years came in Q1 2025 (growth of 845.9%), and the weakest in Q4 2024 (a decline of 43.2%).
- Business Quant data shows TOVX's Non-Current Debt at $1.63 million (Q1 2026), $1.67 million (Q4 2025) and $1.65 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -108.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 51.86 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 23.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 60.50 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Theriva Biologics | 10.10 Mn | 10.10 Mn | - | 1.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.62 Mn |
| Mar 31, 2026 | 1.63 Mn |
| Dec 31, 2025 | 1.67 Mn |
| Sep 30, 2025 | 1.65 Mn |
| Jun 30, 2025 | 1.64 Mn |
| Mar 31, 2025 | 1.50 Mn |
| Dec 31, 2024 | 92,000.00 |
| Sep 30, 2024 | 98,000.00 |
| Jun 30, 2024 | 93,000.00 |
| Mar 31, 2024 | 159,000.00 |
| Dec 31, 2023 | 162,000.00 |
| Sep 30, 2023 | 150,000.00 |
| Jun 30, 2023 | 153,000.00 |
| Mar 31, 2023 | 160,000.00 |
| Dec 31, 2022 | 221,000.00 |
| Sep 30, 2022 | 202,000.00 |
| Jun 30, 2022 | 216,000.00 |
| Mar 31, 2022 | 229,000.00 |
API Access
Theriva Biologics Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=TOVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "TOVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=TOVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();